United States Dog Vaccine Market Report 2018


Report ID : RC-1542 Category : Healthcare Published Date : Oct-18
Publisher : QYResearch Pages : 109 Format : PDF
In this report, the United States Dog Vaccine market is valued at USD XX million in 2018 and is expected to reach USD XX million by the end of 2023, growing at a CAGR of XX% between 2018 and 2023.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Dog Vaccine in these regions, from 2012 to 2023 (forecast).

United States Dog Vaccine market competition by top manufacturers/players, with Dog Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Sanofi-Aventis
    Merial
    Merck
    Pfizer
    Bioniche Animal Health
    Bayer Healthcare
    Zoetis
    Heska Corporation
    Virbac
    Ceva Animal Health
    Boehringer Ingelheim
    Elanco

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Rabies
    Distemper
    Parvovirus
    Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Dog Vaccine for each application, including
    6-8 Weeks
    10-12 Weeks
    12-16 Weeks
    1 Year
    Other
United States Dog Vaccine Market Report 2018
1 Dog Vaccine Overview
    1.1 Product Overview and Scope of Dog Vaccine
    1.2 Classification of Dog Vaccine by Product Category
        1.2.1 United States Dog Vaccine Market Size (Sales Volume) Comparison by Type (2012-2023)
        1.2.2 United States Dog Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2018
        1.2.3 Rabies
        1.2.4 Distemper
        1.2.5 Parvovirus
        1.2.6 Other
    1.3 United States Dog Vaccine Market by Application/End Users
        1.3.1 United States Dog Vaccine Market Size (Consumption) and Market Share Comparison by Application (2012-2023)
        1.3.2 6-8 Weeks
        1.3.3 10-12 Weeks
        1.3.4 12-16 Weeks
        1.3.5 1 Year
        1.3.6 Other
    1.4 United States Dog Vaccine Market by Region
        1.4.1 United States Dog Vaccine Market Size (Value) Comparison by Region (2012-2023)
        1.4.2 The West Dog Vaccine Status and Prospect (2012-2023)
        1.4.3 Southwest Dog Vaccine Status and Prospect (2012-2023)
        1.4.4 The Middle Atlantic Dog Vaccine Status and Prospect (2012-2023)
        1.4.5 New England Dog Vaccine Status and Prospect (2012-2023)
        1.4.6 The South Dog Vaccine Status and Prospect (2012-2023)
        1.4.7 The Midwest Dog Vaccine Status and Prospect (2012-2023)
    1.5 United States Market Size (Value and Volume) of Dog Vaccine (2012-2023)
        1.5.1 United States Dog Vaccine Sales and Growth Rate (2012-2023)
        1.5.2 United States Dog Vaccine Revenue and Growth Rate (2012-2023)

2 United States Dog Vaccine Market Competition by Players/Suppliers
    2.1 United States Dog Vaccine Sales and Market Share of Key Players/Suppliers (2012-2018)
    2.2 United States Dog Vaccine Revenue and Share by Players/Suppliers (2012-2018)
    2.3 United States Dog Vaccine Average Price by Players/Suppliers (2012-2018)
    2.4 United States Dog Vaccine Market Competitive Situation and Trends
        2.4.1 United States Dog Vaccine Market Concentration Rate
        2.4.2 United States Dog Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Dog Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 United States Dog Vaccine Sales (Volume) and Revenue (Value) by Region (2012-2018)
    3.1 United States Dog Vaccine Sales and Market Share by Region (2012-2018)
    3.2 United States Dog Vaccine Revenue and Market Share by Region (2012-2018)
    3.3 United States Dog Vaccine Price by Region (2012-2018)

4 United States Dog Vaccine Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2018)
    4.1 United States Dog Vaccine Sales and Market Share by Type (Product Category) (2012-2018)
    4.2 United States Dog Vaccine Revenue and Market Share by Type (2012-2018)
    4.3 United States Dog Vaccine Price by Type (2012-2018)
    4.4 United States Dog Vaccine Sales Growth Rate by Type (2012-2018)

5 United States Dog Vaccine Sales (Volume) by Application (2012-2018)
    5.1 United States Dog Vaccine Sales and Market Share by Application (2012-2018)
    5.2 United States Dog Vaccine Sales Growth Rate by Application (2012-2018)
    5.3 Market Drivers and Opportunities

6 United States Dog Vaccine Players/Suppliers Profiles and Sales Data
    6.1 Sanofi-Aventis
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Dog Vaccine Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Sanofi-Aventis Dog Vaccine Sales, Revenue, Price and Gross Margin (2012-2018)
        6.1.4 Main Business/Business Overview
    6.2 Merial
        6.2.2 Dog Vaccine Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Merial Dog Vaccine Sales, Revenue, Price and Gross Margin (2012-2018)
        6.2.4 Main Business/Business Overview
    6.3 Merck
        6.3.2 Dog Vaccine Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Merck Dog Vaccine Sales, Revenue, Price and Gross Margin (2012-2018)
        6.3.4 Main Business/Business Overview
    6.4 Pfizer
        6.4.2 Dog Vaccine Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Pfizer Dog Vaccine Sales, Revenue, Price and Gross Margin (2012-2018)
        6.4.4 Main Business/Business Overview
    6.5 Bioniche Animal Health
        6.5.2 Dog Vaccine Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Bioniche Animal Health Dog Vaccine Sales, Revenue, Price and Gross Margin (2012-2018)
        6.5.4 Main Business/Business Overview
    6.6 Bayer Healthcare
        6.6.2 Dog Vaccine Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Bayer Healthcare Dog Vaccine Sales, Revenue, Price and Gross Margin (2012-2018)
        6.6.4 Main Business/Business Overview
    6.7 Zoetis
        6.7.2 Dog Vaccine Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Zoetis Dog Vaccine Sales, Revenue, Price and Gross Margin (2012-2018)
        6.7.4 Main Business/Business Overview
    6.8 Heska Corporation
        6.8.2 Dog Vaccine Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Heska Corporation Dog Vaccine Sales, Revenue, Price and Gross Margin (2012-2018)
        6.8.4 Main Business/Business Overview
    6.9 Virbac
        6.9.2 Dog Vaccine Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Virbac Dog Vaccine Sales, Revenue, Price and Gross Margin (2012-2018)
        6.9.4 Main Business/Business Overview
    6.10 Ceva Animal Health
        6.10.2 Dog Vaccine Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Ceva Animal Health Dog Vaccine Sales, Revenue, Price and Gross Margin (2012-2018)
        6.10.4 Main Business/Business Overview
    6.11 Boehringer Ingelheim
    6.12 Elanco

7 Dog Vaccine Manufacturing Cost Analysis
    7.1 Dog Vaccine Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Dog Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Dog Vaccine Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Dog Vaccine Major Manufacturers in 2018
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Dog Vaccine Market Size (Value and Volume) Forecast (2018-2023)
    11.1 United States Dog Vaccine Sales Volume, Revenue Forecast (2018-2023)
    11.2 United States Dog Vaccine Sales Volume Forecast by Type (2018-2023)
    11.3 United States Dog Vaccine Sales Volume Forecast by Application (2018-2023)
    11.4 United States Dog Vaccine Sales Volume Forecast by Region (2018-2023)

12 Research Findings and Conclusion

Sidebar Menu